Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
CVS Health reported Q2 2024 results and revised its full-year 2024 guidance. Total revenues increased 2.6% to $91.2 billion, while GAAP diluted EPS decreased to $1.41 from $1.48 in the prior year. Adjusted EPS fell to $1.83 from $2.21, primarily due to declining Health Care Benefits segment performance. The company revised its 2024 guidance, lowering GAAP diluted EPS to $4.95-$5.20 from at least $5.64, and Adjusted EPS to $6.40-$6.65 from at least $7.00. Cash flow from operations guidance was reduced to approximately $9.0 billion from at least $10.5 billion. The Health Care Benefits segment faced challenges, including increased utilization and unfavorable Medicare Advantage star ratings impact. In response, CVS announced leadership changes in this segment.
CVS Health (NYSE: CVS) is taking proactive measures to support customers, patients, members, and colleagues as Hurricane Debby makes landfall in Florida and moves through Georgia and the Carolinas. The company is implementing strategies across its business units to ensure continuity of care:
- CVS Pharmacy is reminding patients to refill prescriptions and stocking up on emergency supplies.
- CVS Caremark is enabling emergency prescription refills in affected areas.
- CVS Specialty is arranging alternate delivery for specialty medications.
- Aetna is expanding engagement with Medicare and Commercial members and offering liberalized Resources For Living services.
CVS Health is also supporting employees in affected areas and providing community resources. The company advises customers to follow local evacuation orders and take necessary precautions to ensure access to medications during the hurricane.
CVS Health has launched a groundbreaking initiative to support patients vulnerable to health impacts from extreme weather events, starting with heat waves. The program uses advanced environmental data analytics combined with patient medical and pharmacy data to provide personalized solutions. Initially available to Aetna members, with plans to expand to MinuteClinic and CVS Pharmacy locations, the initiative enables proactive outreach to at-risk patients up to seven days before an extreme weather event.
Care managers offer tailored recommendations, including directing patients to cooling centers, health services, and medication management. In its first two weeks, the program has connected with hundreds of at-risk patients across over 20 states. The initiative aims to improve health outcomes, reduce medical expenditures, and minimize hospital stays and emergency visits. It will expand in the fall to address air pollution-related health risks.
CVS Caremark, the leading pharmacy benefit manager and CVS Health company, has announced a renewed pledge to enhance transparency, reduce drug costs, and improve clinical care. The Caremark Client and Member Pledge focuses on:
1. Delivering greater affordability with an average out-of-pocket cost of less than $8 for a 30-day supply.
2. Promoting lowest net cost drugs.
3. Strengthening alignment between benefit design, physician choice, and patient need.
4. Innovating for greater transparency with the new TrueCost™ solution.
5. Encouraging pharmacy models that deliver rebate value directly to patients.
6. Improving relations with pharmacies.
7. Changing the trajectory of drug costs.
CVS Caremark aims to be a counterweight against pharmaceutical price hikes and continue putting medicine within reach for millions of Americans.
CVS Health announced that its Board of Directors has approved a quarterly dividend of $0.665 per share of Common Stock.
The dividend will be paid on August 1, 2024, to shareholders recorded by July 22, 2024.
CVS Health (NYSE: CVS) announced that it will hold a conference call with analysts and investors on Wednesday, August 7, 2024, at 8:00 a.m. ET to discuss its second quarter 2024 financial results.
The audio webcast of the event will be available live on the Investor Relations section of the CVS Health website and will be archived for one year. The call will provide insights into the company's financial performance and strategic initiatives.
CVS Health announced that President and CEO Karen S. Lynch and EVP and CFO Tom Cowhey will participate in the Bernstein 40th Annual Strategic Decisions Conference on May 29, 2024, at 10:00 am ET.
The event will include a fireside chat with investors.
An audio webcast of the event will be available live and archived for one year on the CVS Health Investor Relations website.
CVS Pharmacy has launched Well Market, a new store brand featuring 40 snacks, beverages, and groceries. The products are available nationwide and online. Well Market aims to offer nutritious and flavorful options, including innovative items like flavor-infused sprouted almonds. The line is designed to meet various dietary needs such as vegan, gluten-free, and keto. Existing brands Gold Emblem and Big Chill will be integrated under Well Market. Prices range from $2.99 to $8.99, and all products come with a 100% money-back guarantee. Packaging will be recyclable by 2030.
A recent CVS Health survey conducted by Morning Consult revealed that concerns about mental health are on the rise, surpassing levels seen during the COVID-19 pandemic. The survey found that two-thirds of adults are worried about their mental health or that of their loved ones. Concerns about mental health have increased by 15% since 2020, with 77% of adults viewing it as a top issue alongside the economy. Parents are particularly concerned about their children's mental well-being. The survey also highlighted the impact of social media on mental health, with many adults turning to mental well-being apps and therapists for support. CVS Health remains committed to improving access to mental health care through both virtual and in-person services.
CVS Health (NYSE: CVS) will be represented by Chief Financial Officer Tom Cowhey at the Bank of America 2024 Healthcare Conference on May 14, 2024. The event will include a fireside chat with investors, which will be available via audio webcast on the CVS Health Investor Relations website for one year.